Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Mettler Toledo Launches the Oxygen Sensors for Biopharma Applications

Published: Monday, November 12, 2012
Last Updated: Sunday, November 11, 2012
Bookmark and Share
Advanced optical technology raises the benchmark for easy handling combined with exceptional performance.

Mettler Toledo Process Analytics has announced the launch of the InPro 6860i, a series of dissolved oxygen (DO) sensors for the biopharma industry.

InPro 6860i sensors combine a highly accurate and reliable optical measurement technique with automatic drift compensation and plug-and-measure installation.

Central to the operational benefits of the new sensors is Mettler Toledo's Intelligent Sensor Management (ISM) concept, simplifying sensor handling and maintenance with advanced features not available on non-ISM sensors.

ISM's predictive diagnostics enable operators to determine easily lnPro 6860i sensors require maintenance before its next use. Sensors based on optical measurement are favored in biofermentation processes as they exhibit low drift.

With the InPro 6860i, any drift that occurs is automatically compensated for by the ISM technology. These two features provide high measurement stability and assure batch-to-batch consistency maintenance.

For installation flexibility, InPro 6860i DO sensors output a digital signal for use with ISM transmitters and an analog (nA) signal for biocontrollers.

Hygienic design requirements are addressed with a Teflon® coated and O-ring-free sensing element which resists biofouling and is easily cleaned.

"Mettler Toledo’s new DO sensors offer unequalled performance and ease of handling,” says Jürgen Illerhaus, head of product management at Mettler Toledo Process Analytics.”

Combined with the outstanding robustness and user friendliness of the sensor, we are able to meet the demanding process requirements from direct integration in bench top fermenters to validated production processes."


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Pharma Tech Trends and Development Cost Solutions
METTLER TOLEDO’s new on-demand webinar, “Methods to Improve Chemical Process Development,” takes on the challenges of today’s pharmaceutical market.
Thursday, April 04, 2013
Scientific News
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Lemon Juice and Human Norovirus
Citric acid may prevent the highly contagious norovirus from infecting humans, scientists discovered from the German Cancer Research Center.
Study Backs Flu Vaccinations for Elderly
Brown University researchers found vaccines well matched to the year’s flu strain significantly reduce deaths and hospitalizations compared to when the match is poor, suggesting that vaccination indeed makes a difference.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Protein Found to Play a Key Role in Blocking Pathogen Survival
Calprotectin fends off microbial invaders by limiting access to iron, an important nutrient.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!